Chargement en cours...
Anti-vascular endothelial growth factor therapies in ophthalmology: current use, controversies and the future
Use of anti-vascular endothelial growth factor (VEGF) therapies was introduced for the treatment of ocular disorders in 2005. In the UK, the current licensed and NICE approved indications are for the treatment of neovascular age-related macular degeneration (nAMD), diabetic macular oedema (DMO), mac...
Enregistré dans:
| Publié dans: | Br J Clin Pharmacol |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BlackWell Publishing Ltd
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4239964/ https://ncbi.nlm.nih.gov/pubmed/24602183 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12371 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|